Sponsor Pipeline

Yongsheng Wang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07699952 First-line Therapy With EGFR-TKI Combined With Trastuzumab Rezetecan for Advanced NSCLC… Lung Cancer (NSCLC) Not Yet Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when Yongsheng Wang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free